Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 3 8Phase NA 5Phase 1 5Phase 1/2 4Phase 4 3

Status

Recruiting 5Active not recruiting 3

Sponsor Class

INDUSTRY 6OTHER 2

Study Type

Interventional 8

Sponsor

Cancer Type

Myeloid 8Classical hematology 1

Conditions

Breast Neoplasms 245Carcinoma, Non-Small-Cell Lung 225Prostatic Neoplasms 113Neoplasms 104Multiple Myeloma 90Neoplasm Metastasis 75Colorectal Neoplasms 73Parkinson Disease 4, Autosomal Dominant Lewy Body 69Lung Neoplasms 66Ovarian Neoplasms 61Leukemia, Myeloid, Acute 50Carcinoma, Hepatocellular 47Melanoma 46Leukemia, Lymphocytic, Chronic, B-Cell 44Carcinoma, Renal Cell 43Urinary Bladder Neoplasms 41Stomach Neoplasms 41Squamous Cell Carcinoma of Head and Neck 41Triple Negative Breast Neoplasms 40Recurrence 40Brain Neoplasms 40Myasthenia Gravis 37Small Cell Lung Carcinoma 35Lymphoma, Follicular 35Nasopharyngeal Carcinoma 34Head and Neck Neoplasms 33Pancreatic Neoplasms 32Rectal Neoplasms 30Lymphoma, Large B-Cell, Diffuse 30Colonic Neoplasms 29

Interventions

Hydroxyurea 2ruxolitinib 1givinostat hydrochloride 1givinostat 1bomedemstat 1N(4)-oleylcytosine arabinoside 1Interferons 1Interferon-alpha 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 3 × Polycythemia Vera × 1 year × Clear all
NCT07429266 2026-06-05

INTREPID

Ono Pharmaceutical Co., Ltd.

Phase 3 Recruiting
250 enrolled
Myeloid

Polycythemia Vera

NCT04116502 2026-04-28

MITHRIDATE

University of Birmingham

Phase 3 Recruiting
586 enrolled
Myeloid

Polycythemia Vera

NCT06351631 2026-04-02

MK-3543-017

Merck Sharp & Dohme LLC

Phase 3 Recruiting
400 enrolled
Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT06093672 2026-03-25

GIV-IN-PV

Italfarmaco

Phase 3 Recruiting
220 enrolled
Myeloid

Polycythemia Vera

NCT05198960 2026-03-20

AVAJAK

University Hospital, Brest

Phase 3 Recruiting
1,308 enrolled
Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT05481151 2025-08-13

A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

PharmaEssentia

Phase 3 Active not recruiting
111 enrolled
Myeloid

Polycythemia, Polycythemia Vera, Thrombocythemia, Essential

NCT05210790 2025-08-07

VERIFY

Protagonist Therapeutics, Inc.

Phase 3 Active not recruiting
293 enrolled
Myeloid

Polycythemia Vera

NCT06033586 2025-08-06

THRIVE

Protagonist Therapeutics, Inc.

Phase 3 Active not recruiting
46 enrolled
Myeloid

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon âš¡